pharmaceutical-investing OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
pharmaceutical-investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
pharmaceutical-investing DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer